z-logo
open-access-imgOpen Access
Application of Parallel Importation and Voluntary License in the Covid-19 Vaccines Patent as a Strategy for Handling the Health Emergency Situations in Indonesia
Author(s) -
Kukuh Tejomurti,
Pujiyono Pujiyono,
Pranoto Pranoto,
Umi Khaerah Pati
Publication year - 2021
Publication title -
hang tuah law journal
Language(s) - English
Resource type - Journals
eISSN - 2549-2071
pISSN - 2549-2055
DOI - 10.30649/htlj.v4i2.13
Subject(s) - license , lawsuit , government (linguistics) , business , monopoly , statute , covid-19 , law , economics , political science , medicine , infectious disease (medical specialty) , philosophy , linguistics , disease , pathology , market economy
This article examines how the application of Parallel Importation and Voluntary License in the Application of the Covid-19 Vaccine Patent as a Strategy for Handling Health Emergency Situations in Indonesia. The problem of the Covid-19 vaccine happens in many countries around the world, including Indonesia whos trying to find a vaccine that can neutralize the Covid-19 Virus. As a consequence of the tremendous demand for vaccines, the world pharmaceutical industry is encouraged to provide Covid-19 vaccines for the needs of 7.8 billion. This article uses normative legal research with a statute, conceptual, and comparative law approach. The results showed that mechanisms such as parallel importation and voluntary licenses could be reached to procure the Covid-19 vaccine. If parallel importation and voluntary licenses are not successful, then the Government shall take a win-lose approach, such as Compulsory Licensing and Use of Patents by the Government, or initiate an anti-monopoly lawsuit.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom